Dr. Edmund Pribitkin, CMO of Thomas Jefferson University Hospitals, approached Smithwise with a proposed solution--embedding an auto-injector for epinephrine into the case of a smartphone.
This project is based on an issued US patent held by Thomas Jefferson University, US 10,022,506.
Jefferson is currently pursuing partnership opportunities for this device. For further information, please click here.
"Partnering with Smithwise was extraordinarily gratifying—their engineering know-how brought our product from patent to prototype in record time and with refinements that will improve patient safety and increase consumer adoption."
Edmund Pribitkin, MD, MBA